1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America PCR for Respiratory Infection Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America PCR for Respiratory Infection Diagnostics Market Regional Analysis
6.2 North America PCR for Respiratory Infection Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America PCR for Respiratory Infection Diagnostics Market Forecast Analysis
7. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Type
7.1 Real-Time PCR
- 7.1.1 Overview
- 7.1.2 Real-Time PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Multiplex PCR
- 7.2.1 Overview
- 7.2.2 Multiplex PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Traditional PCR
- 7.3.1 Overview
- 7.3.2 Traditional PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Reverse-Transcriptase
- 7.5.1 Overview
- 7.5.2 Reverse-Transcriptase: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Product Type
8.1 Reagents & Kits
- 8.1.1 Overview
- 8.1.2 Reagents & Kits: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Instruments
- 8.2.1 Overview
- 8.2.2 Instruments: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Infection Type
9.1 Bacterial Infections
- 9.1.1 Overview
- 9.1.2 Bacterial Infections: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Viral Infections
- 9.2.1 Overview
- 9.2.2 Viral Infections: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Fungal & Other Pathogens
- 9.3.1 Overview
- 9.3.2 Fungal & Other Pathogens: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America PCR for Respiratory Infection Diagnostics Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Physician Clinics
- 10.2.1 Overview
- 10.2.2 Physician Clinics: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.4 Academic & Research Institutions
- 10.4.1 Overview
- 10.4.2 Academic & Research Institutions: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.5 Biotech & Pharma Companies
- 10.5.1 Overview
- 10.5.2 Biotech & Pharma Companies: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. North America PCR for Respiratory Infection Diagnostics Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 11.2.1.1 North America PCR for Respiratory Infection Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.1.2 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.1.3 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.1.4 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.2 Canada:
North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.2.2 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.2.3 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.2.4 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.3.2 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.3.3 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.3.4 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Hologic, Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 BD
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 bioMerieux SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 QIAGEN
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Seegene Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America PCR for Respiratory Infection Diagnostics Market
